BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15483128)

  • 21. Initial coupling of binding to gating mediated by conserved residues in the muscle nicotinic receptor.
    Mukhtasimova N; Free C; Sine SM
    J Gen Physiol; 2005 Jul; 126(1):23-39. PubMed ID: 15955875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candidate amino acids involved in H+ gating of acid-sensing ion channel 1a.
    Paukert M; Chen X; Polleichtner G; Schindelin H; Gründer S
    J Biol Chem; 2008 Jan; 283(1):572-581. PubMed ID: 17981796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The L293 residue in transmembrane domain 2 of the 5-HT3A receptor is a molecular determinant of allosteric modulation by 5-hydroxyindole.
    Hu XQ; Lovinger DM
    Neuropharmacology; 2008 Jun; 54(8):1153-65. PubMed ID: 18436267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of valine 7' of TMD2 to gating of neuronal alpha3 receptor subtypes.
    Nieves-Cintrón M; Caballero-Rivera D; Navedo MF; Lasalde-Dominicci JA
    J Neurosci Res; 2006 Dec; 84(8):1778-88. PubMed ID: 17044037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A role for the Val291 residue within the transmembrane domain 2 in diltiazem- and TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester]-mediated 5-hydroxytryptamine type 3A receptor regulations.
    Lee BH; Choi SH; Pyo MK; Shin TJ; Hwang SH; Kim BR; Lee JH; Rhim H; Kim HC; Nah SY
    Biol Pharm Bull; 2009 May; 32(5):861-7. PubMed ID: 19420755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyr-167/Trp-168 in type 1/3 inositol 1,4,5-trisphosphate receptor mediates functional coupling between ligand binding and channel opening.
    Yamazaki H; Chan J; Ikura M; Michikawa T; Mikoshiba K
    J Biol Chem; 2010 Nov; 285(46):36081-91. PubMed ID: 20813840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proline Residues in the Transmembrane/Extracellular Domain Interface Loops Have Different Behaviors in 5-HT
    Mosesso R; Dougherty DA; Lummis SCR
    ACS Chem Neurosci; 2019 Jul; 10(7):3327-3333. PubMed ID: 31273982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role for the beta 1-beta 2 loop in the gating of 5-HT3 receptors.
    Reeves DC; Jansen M; Bali M; Lemster T; Akabas MH
    J Neurosci; 2005 Oct; 25(41):9358-66. PubMed ID: 16221844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of granisetron with an agonist-free 5-HT3A receptor model.
    Joshi PR; Suryanarayanan A; Hazai E; Schulte MK; Maksay G; Bikádi Z
    Biochemistry; 2006 Jan; 45(4):1099-105. PubMed ID: 16430206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resveratrol enhances 5-hydroxytryptamine type 3A receptor-mediated ion currents: the role of arginine 222 residue in pre-transmembrane domain I.
    Lee BH; Hwang SH; Choi SH; Shin TJ; Kang J; Lee SM; Nah SY
    Biol Pharm Bull; 2011; 34(4):523-7. PubMed ID: 21467640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the ligand binding site of the 5-HT3 receptor using site directed mutagenesis: importance of glutamate 106.
    Boess FG; Steward LJ; Steele JA; Liu D; Reid J; Glencorse TA; Martin IL
    Neuropharmacology; 1997; 36(4-5):637-47. PubMed ID: 9225289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical-scale studies on the role of a conserved aspartate in preorganizing the agonist binding site of the nicotinic acetylcholine receptor.
    Cashin AL; Torrice MM; McMenimen KA; Lester HA; Dougherty DA
    Biochemistry; 2007 Jan; 46(3):630-9. PubMed ID: 17223685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for a centrally located gate in the pore of a serotonin-gated ion channel.
    Panicker S; Cruz H; Arrabit C; Slesinger PA
    J Neurosci; 2002 Mar; 22(5):1629-39. PubMed ID: 11880493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective profiling of N- and C-terminal nucleotide-binding sites in a TRPM2 channel.
    Tóth B; Iordanov I; Csanády L
    J Gen Physiol; 2020 May; 152(5):. PubMed ID: 32211872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transducing agonist binding to channel gating involves different interactions in 5-HT3 and GABAC receptors.
    Price KL; Millen KS; Lummis SC
    J Biol Chem; 2007 Aug; 282(35):25623-30. PubMed ID: 17606617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contributions of the non-alpha subunit residues (loop D) to agonist binding and channel gating in the muscle nicotinic acetylcholine receptor.
    Akk G
    J Physiol; 2002 Nov; 544(3):695-705. PubMed ID: 12411516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isomerization of the proline in the M2-M3 linker is not required for activation of the human 5-HT3A receptor.
    Paulsen IM; Martin IL; Dunn SM
    J Neurochem; 2009 Aug; 110(3):870-8. PubMed ID: 19457066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A coupled array of noncovalent interactions impacts the function of the 5-HT3A serotonin receptor in an agonist-specific way.
    Miles TF; Bower KS; Lester HA; Dougherty DA
    ACS Chem Neurosci; 2012 Oct; 3(10):753-60. PubMed ID: 23077719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subunit-dependent modulation of the 5-hydroxytryptamine type 3 receptor open-close equilibrium by n-alcohols.
    Rüsch D; Musset B; Wulf H; Schuster A; Raines DE
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1069-74. PubMed ID: 17360702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Cys-loop superfamily of ligand-gated ion channels: the impact of receptor structure on function.
    Connolly CN; Wafford KA
    Biochem Soc Trans; 2004 Jun; 32(Pt3):529-34. PubMed ID: 15157178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.